Skip to main content
Loading ResearchHub…
References for Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations | ResearchHub - ResearchHub